Cargando…

The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction

OBJECTIVE: SCUBE1 [signal peptide-CUB (complement C1r/C1 s)-EGF (epidermal growth factor)-like domain-containing protein 1] might function as a novel platelet-endothelial adhesion molecule and play pathological roles in cardiovascular biology. Acute myocardial infarction is one of the most common ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolayır, Hasan Ata, Güneş, Hakan, Kıvrak, Tarık, Şahin, Ömer, Akaslan, Dursun, Kurt, Recep, Bolayır, Aslı, İmadoğlu, Oya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731261/ https://www.ncbi.nlm.nih.gov/pubmed/28554990 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7705

Ejemplares similares

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

The biology of SCUBE
por: Lin, Yuh-Charn, et al.
Publicado: (2023)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Tascanov, Mustafa Begenc, et al.
Publicado: (2019)

The role of systemic ımmune ınflammatory ındex in showing active lesion ın patients with multiple sclerosis: SII and other inflamatuar biomarker in radiological active multiple sclerosis patients
por: Gokce, Seyda Figul, et al.
Publicado: (2023)

Serum SCUBE-1 Levels and Return of Spontaneous Circulation Following Cardiopulmonary Resuscitation in Adult Patients
por: Yılmaz, Cahit, et al.
Publicado: (2022)

Predictive value of the systemic immune inflammatory index in cardiac syndrome x
por: Akın, Yusuf, et al.
Publicado: (2023)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Mechanical and thermal properties of polyamide versus reinforced PMMA denture base materials
por: Soygun, Koray, et al.
Publicado: (2013)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data?
por: Namazi, Mohammadhasan, et al.
Publicado: (2021)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
por: Kożuch, Marcin, et al.
Publicado: (2022)

The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2018)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention
por: Badran, Hala Mahfouz, et al.
Publicado: (2020)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2022)

Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction
por: Li, Junxia, et al.
Publicado: (2015)

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2022)

Investigations on the effects of mouthrinses on the colour stability and surface roughness of different dental bioceramics
por: Soygun, Koray, et al.
Publicado: (2017)

A study on the discoloration of different dental porcelain systems
por: Ulucan, Mehmet Cagatay, et al.
Publicado: (2023)

Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2022)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Upregulation of SCUBE1 in Dengue Virus Infection
por: Ali, Hirowati, et al.
Publicado: (2019)

SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients
por: Toprak, Kenan, et al.
Publicado: (2022)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
por: Wang, Zuoyan, et al.
Publicado: (2018)

Platelet‐Lymphocyte ratio is a predictor for the development of no‐reflow phenomenon in patients with ST‐segment elevation myocardial infarction after thrombus aspiration
por: ŞENÖZ, Oktay, et al.
Publicado: (2021)

RDW as A Predictor for No-Reflow Phenomenon in DM Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Sun, Ying, et al.
Publicado: (2023)

No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications
por: Ahn, Seong Joon, et al.
Publicado: (2015)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction()
por: Katayama, Yosuke, et al.
Publicado: (2022)

Dermatoglyphic features in patients with multiple sclerosis
por: Sabanciogullari, Vedat, et al.
Publicado: (2014)

Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI
por: Li, Hui, et al.
Publicado: (2018)

Prevalence of multiple sclerosis in an urban population of Sivas province in Turkey
por: GÖKÇE, Şeyda Figül, et al.
Publicado: (2019)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Delayed Treatment With Hypothermia Protects Against the No‐Reflow Phenomenon Despite Failure to Reduce Infarct Size
por: Hale, Sharon L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8q9430v6s47ustml6eske87pok